EXPE vs KRYS · P/E 20, rev $7.74B vs P/E 46, rev $235.6M
Expedia Group Inc. (EXPE) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the EXPE and KRYS stock pages for the full models.
Not investment advice.